Ecs Botanics Holdings Stock Short Ratio
ECS Stock | 0.02 0.0005 3.13% |
ECS Botanics Holdings fundamentals help investors to digest information that contributes to ECS Botanics' financial success or failures. It also enables traders to predict the movement of ECS Stock. The fundamental analysis module provides a way to measure ECS Botanics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ECS Botanics stock.
ECS | Short Ratio |
ECS Botanics Holdings Company Short Ratio Analysis
ECS Botanics' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Competition |
ECS Discontinued Operations
Discontinued Operations |
|
Based on the latest financial disclosure, ECS Botanics Holdings has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Pharmaceuticals sector and about the same as Health Care (which currently averages 0.0) industry. The short ratio for all Australia stocks is 100.0% higher than that of the company.
Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
All Next | Launch Module |
ECS Fundamentals
Return On Equity | 0.076 | ||||
Return On Asset | 0.0397 | ||||
Profit Margin | 0.1 % | ||||
Operating Margin | 0.07 % | ||||
Current Valuation | 17.58 M | ||||
Shares Outstanding | 1.3 B | ||||
Shares Owned By Insiders | 36.69 % | ||||
Price To Book | 0.76 X | ||||
Price To Sales | 1.04 X | ||||
Revenue | 20.03 M | ||||
Gross Profit | 7.51 M | ||||
EBITDA | 3.24 M | ||||
Net Income | 1.92 M | ||||
Cash And Equivalents | 1.87 M | ||||
Total Debt | 1.02 M | ||||
Book Value Per Share | 0.02 X | ||||
Cash Flow From Operations | (1.49 M) | ||||
Beta | 1.28 | ||||
Market Capitalization | 20.74 M | ||||
Total Asset | 32.88 M | ||||
Retained Earnings | (8.73 M) | ||||
Working Capital | 15.8 M | ||||
Net Asset | 32.88 M |
About ECS Botanics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ECS Botanics Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ECS Botanics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ECS Botanics Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ECS Stock Analysis
When running ECS Botanics' price analysis, check to measure ECS Botanics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ECS Botanics is operating at the current time. Most of ECS Botanics' value examination focuses on studying past and present price action to predict the probability of ECS Botanics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ECS Botanics' price. Additionally, you may evaluate how the addition of ECS Botanics to your portfolios can decrease your overall portfolio volatility.